ARCHIVES

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: AACR Grants Record Number Of Awards To Young Investigators; Kersey Leads ASBMT

April 24, 1998

Toxic Substance Act Would Affect Cancer Program

March 21, 1975

Aranesp Approval Introduces Competition To $1.8 Billion U.S. Cancer Anemia Market

August 2, 2002

Two-Drug Combination Extends Survival Of Mesothelioma

May 31, 2002

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

June 27, 2014

Bioassay Report Clears EDTA

August 12, 1977